💊 Tretinoin (Tretinoin)
Tretinoin capsules are an oral retinoid used to induce remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL). It must be used under a doctor's supervision and carries a boxed warning for embryo-fetal toxicity and Differentiation Syndrome.
In Arabic: تريتينوين (حمض الريتينويك الكامل ترانس)🏷️ Brand names & manufacturers
Retin-a Micro🏭 Bausch Health US LLCDailyMed
Altreno🏭 Bausch Health US, LLCDailyMed
Retin-a🏭 Bausch Health US, LLCDailyMed
Renova🏭 Bausch Health US LLCDailyMed
Atralin🏭 Bausch Health US, LLCDailyMed
Tretinoin Cream🏭 Obagi Cosmeceuticals LLCDailyMed✅ What it is used for
- Induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL) characterized by the t(15;17) translocation or PML/RARα gene expression
- For patients who are refractory to or have relapsed from anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated
🧪 Active ingredient
The active substance is tretinoin (all-trans retinoic acid), a retinoid. It induces maturation and decreases proliferation of APL cells; in patients achieving complete remission, bone marrow and peripheral blood are repopulated by normal, polyclonal blood cells. The exact mechanism of action in APL is unknown.
🌿 Benefits
- Helps achieve remission in appropriate patients with acute promyelocytic leukemia
📝 How to use
- The dose is set by your doctor or pharmacist and must not be changed without consulting them
- Take the capsules with a meal
- Swallow capsules whole with water; do not chew, dissolve, or open them
- If you vomit after a dose, do not take an extra dose; continue with the next scheduled dose
💊 Dosage forms
- 10 mg capsules, two-tone (reddish-brown opaque and yellow) imprinted with “TR” in black ink on the yellow side
⚠️ Common side effects
- Headache
- Fever
- Skin/mucous membrane dryness
- Bone pain
- Malaise
- Shivering
- Upper respiratory tract disorders and dyspnea
- Hemorrhage
- Infections
- Nausea/vomiting
- Rash
- Peripheral edema
- Leukocytosis
- Pain
- Chest discomfort
- Abdominal pain
🚨 Serious — seek medical help
- Differentiation Syndrome (can be life-threatening or fatal; occurred in about 26% of patients)
- Benign intracranial hypertension, especially in pediatric patients
- Hypercholesterolemia and/or hypertriglyceridemia
- Hepatotoxicity
- Venous and arterial thromboembolic events
- Hypersensitivity reactions: rash, pruritus, face edema, dyspnea
⛔ Do not use if
- Known hypersensitivity to tretinoin, any of its components, or other retinoids
❗ Warnings & precautions
- Boxed warning: can cause embryo-fetal loss and malformations when administered to a pregnant woman
- Females of reproductive potential must have a negative pregnancy test before starting
- Differentiation Syndrome: at first signs or symptoms, immediately initiate high-dose corticosteroids with hemodynamic monitoring; consider withholding tretinoin for moderate and severe cases
- Confirm APL diagnosis by detecting t(15;17) translocation or PML/RARα fusion; discontinue if not identified
- Leukocytosis: consider cytoreductive chemotherapy as clinically indicated
- Intracranial hypertension: consider interruption, dose reduction, or discontinuation
- Monitor fasting triglycerides and cholesterol at baseline and periodically
- Monitor liver function tests at baseline and during treatment as clinically indicated
- Thromboembolic events may occur during the first month of treatment
🔄 Drug interactions
- Strong CYP3A inhibitors: avoid if possible; monitor more frequently if unavoidable (increase tretinoin levels)
- Moderate CYP3A inhibitors: monitor more frequently for adverse reactions
- Strong CYP3A inducers: avoid; may decrease tretinoin levels and efficacy
- Products causing intracranial hypertension (e.g., tetracyclines): avoid concomitant use
- Vitamin A: avoid concomitant use due to vitamin A-related adverse reactions
- Anti-fibrinolytic agents: fatal thrombotic complications reported; avoid concomitant use
🤰 Pregnancy
Tretinoin can cause embryo-fetal loss and malformations. As a retinoid, it increases the risk of major congenital malformations, spontaneous abortions and premature births. A negative pregnancy test is required before starting. Females of reproductive potential should use 2 effective methods of contraception during treatment and for 1 month after the last dose. Males with female partners of reproductive potential should use effective contraception during treatment and for 1 week after the last dose.
🍼 Breastfeeding
Advise not to breastfeed during treatment.
🧒 Children
Safety and effectiveness are established in pediatric patients 1 year of age and older. The maximum tolerated dose is lower than in adults, and some children experience severe headache and intracranial hypertension. Dose reduction may be considered for serious or intolerable adverse reactions. Safety and effectiveness in patients under 1 year have not been established.
👴 Older adults
No overall differences in safety or effectiveness were observed between patients 60 years and older (21% of study participants) and younger patients.
🌡️ Storage
Store at 20°C to 25°C (68°F to 77°F). Keep the container tightly closed, protect from light, and keep out of the reach of children.
⏰ Missed dose
Do not take a missed dose unless it is more than 10 hours until the next scheduled dose. If in doubt, ask your doctor or pharmacist.
🆘 Overdose
Reversible signs of hypervitaminosis A (headache, nausea, vomiting, mucocutaneous symptoms) can appear; facial flushing, abdominal pain, dizziness and ataxia have been seen with other retinoids. There is no specific treatment, and the patient should be treated in a special hematological unit. Seek medical help immediately.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| ROOTAN 0.05% CREAM TRETINOIN 0.05% | Jepharm Co. | TUBE OF 20 GM | 18 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Tretinoin induces cytodifferentiation and decreased proliferation of APL cells in culture and in vivo. In APL patients it produces initial maturation of primitive promyelocytes from the leukemic clone, followed by repopulation of bone marrow and peripheral blood with normal, polyclonal hematopoietic cells in those achieving CR. The exact mechanism is unknown. Pharmacokinetics: Tmax 1–2 h, absolute bioavailability ~50%, protein binding >95%, terminal half-life 0.5–2 h, induces its own metabolism (plasma concentrations fall to one-third after 1 week), metabolized by CYP3A4, 2C8, 2E and glucuronidated by UGT2B7.
Labeled dosing
Label adult dosage: 22.5 mg/m² orally twice daily until complete remission is documented; discontinue 30 days after achievement of complete remission or after 90 days of treatment, whichever occurs first. Take with a meal and swallow whole. The final dose is determined by the prescribing physician.
- Verify pregnancy status in females of reproductive potential before initiating
- Discontinue if t(15;17) translocation or PML/RARα fusion is not identified
- Manage Differentiation Syndrome with immediate high-dose corticosteroids and hemodynamic monitoring
- Monitor fasting lipids and liver function tests
- Consider dose reduction in pediatric patients with serious/intolerable adverse reactions
🎓 Key points for students
- Oral retinoid for APL with t(15;17) / PML-RARα
- Boxed warning: embryo-fetal toxicity and Differentiation Syndrome (~26%)
- Dose 22.5 mg/m² BID until CR; stop 30 days after CR or at 90 days
- CYP3A4 substrate that induces its own metabolism
- Avoid with vitamin A, tetracyclines, anti-fibrinolytics, and strong CYP3A inhibitors/inducers
- Common adverse effects: headache, fever, mucocutaneous dryness, bone pain
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What are tretinoin capsules used for?
They are used to induce remission in adults and children 1 year and older with acute promyelocytic leukemia (APL) in specific situations determined by the doctor.
How should I take the capsules?
Take with a meal and swallow whole with water; do not chew, dissolve, or open them. Your doctor or pharmacist sets the dose.
Can it be used during pregnancy?
No. It can cause embryo-fetal loss and malformations. A negative pregnancy test is needed before starting, with two effective contraception methods during treatment and for 1 month after the last dose.
What is Differentiation Syndrome?
A potentially life-threatening or fatal condition occurring in about 26% of patients. Tell your doctor immediately at the first signs so high-dose corticosteroid treatment can begin.
What if I miss a dose?
Do not take it unless it is more than 10 hours until the next scheduled dose. If you vomit after a dose, do not take an extra dose.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-05), simplified. Updated: 2026-11-16.